R.I. researchers test nanoparticles in fight against rare bone cancer

TACTICAL TECH: Dr. Richard Terek, right, chief of musculoskeletal surgery at Rhode Island Hospital, and Qian Chen, director of the hospital’s Center for Biomedical Research Excellence in Skeletal Health and Repair, have developed nanoparticles to deliver medicine to limit the growth of bone cancer tumors. / PBN PHOTO/MIKE SKORSKI
TACTICAL TECH: Dr. Richard Terek, right, chief of musculoskeletal surgery at Rhode Island Hospital, and Qian Chen, director of the hospital’s Center for Biomedical Research Excellence in Skeletal Health and Repair, have developed nanoparticles to deliver medicine to limit the growth of bone cancer tumors. / PBN PHOTO/MIKE SKORSKI
For the past 26 years, Dr. Richard Terek has been treating bone cancer patients at Rhode Island Hospital in Providence. Some forms of the disease respond fairly well to treatment, but one rare type of bone cancer is notoriously resistant to intervention. Chondrosarcoma begins in the bones and spreads if not caught in time. Its…

Subscriber-only Content

Subscribe to PBN today to read this article.
Get unlimited access for $1 for 4 weeks.

Subscribe for $1

Already a subscriber? Login now.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -